Status:
COMPLETED
Message-Based Psychotherapy and Digital Treatment Sequences for Depression
Lead Sponsor:
Talkspace
Collaborating Sponsors:
University of Washington
Conditions:
Study Adherence
Depressive Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This partnership between Talkspace and the University of Washington (UW) ALACRITY Center will determine how effective unlimited text-based psychotherapy for depression is when compared to once-a-week ...
Detailed Description
This is a fast track Small Business Innovation Research (SBIR) proposal that will (1) test the effectiveness of daily, message-based psychotherapy (MBP) for depression, compared to traditionally deliv...
Eligibility Criteria
Inclusion
- Inclusion and exclusion criteria are the same for Phase 1 and Phase 2.
- 18 years old or older
- English or Spanish speaking
- Live in the United States
- Score of 10 or greater on the Patient Health Questionnaire-9 (PHQ-9) screening
- Receive a diagnosis of depression from a Talkspace intake clinician
Exclusion
- Under the age of 18
- Non-English or Spanish speaking
- Do not meet criteria for a depressive disorder
- Participants with active suicidal ideation or with a primary diagnosis of psychosis will also be excluded and referred to intensive care.
Key Trial Info
Start Date :
March 2 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 14 2024
Estimated Enrollment :
1184 Patients enrolled
Trial Details
Trial ID
NCT04513080
Start Date
March 2 2020
End Date
January 14 2024
Last Update
October 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Talkspace
New York, New York, United States, 10025